Back
SPDR® S&P Pharmaceuticals ETF Vs. ePlus Industry Stock Comparison
Buy
59
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
46.28
Seasonality Move:
4.28%
Sell
29
PLUS
ePlus
Last Price:
80.50
Seasonality Move:
20.86%
Buy
59
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $46.29. The Score for XPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- XPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
ePlus (PLUS)
is a Sell
Is ePlus a Buy, Sell or Hold?
- The current ePlus [PLUS] share price is $80.48. The Score for PLUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $46.29
The current trend is moderately bearish and XPH is experiencing selling pressure, which indicates risk of future bearish movement.
PLUS Stock Price Chart
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 49.35 | Sell |
| Chaikin Money Flow: | -14737 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.84 - 47.4) | Sell |
| Bollinger Bands (100): | (41.64 - 45.94) | Buy |
PLUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.29 | Sell |
| Relative Strength Index (14 RSI): | 29.13 | Sell |
| Chaikin Money Flow: | -131262 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.57 - 100.91) | Sell |
| Bollinger Bands (100): | (81.36 - 98.26) | Sell |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.29 | Sell |
| 20-day SMA: | 46.71 | Sell |
| 50-day SMA: | 45.33 | Buy |
| 200-day SMA: | 42.78 | Buy |
| 8-day EMA: | 47.06 | Sell |
| 20-day EMA: | 46.64 | Sell |
| 50-day EMA: | 45.56 | Buy |
| 200-day EMA: | 43.14 | Buy |
PLUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.25 | Sell |
| 20-day SMA: | 94.05 | Sell |
| 50-day SMA: | 95.08 | Sell |
| 200-day SMA: | 83.6 | Sell |
| 8-day EMA: | 89.64 | Sell |
| 20-day EMA: | 92.96 | Sell |
| 50-day EMA: | 93.52 | Sell |
| 200-day EMA: | 84.4 | Sell |
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ePlus Earnings Growth & PLUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
SPDR® S&P Pharmaceuticals ETF Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ePlus Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||